Young Kwon - Net Worth and Insider Trading

Young Kwon Net Worth

The estimated net worth of Young Kwon is at least $13 Million dollars as of 2024-11-07. Young Kwon is the Chief Financial & Bus. Officer of Momenta Pharmaceuticals Inc and owns about 160,633 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $8 Million. Young Kwon is also the Director of ADMA Biologics Inc and owns about 241,441 shares of ADMA Biologics Inc (ADMA) stock worth over $5 Million. Details can be seen in Young Kwon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Young Kwon has not made any transactions after 2024-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Young Kwon

To

Young Kwon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Young Kwon owns 2 companies in total, including Momenta Pharmaceuticals Inc (MNTA) , and ADMA Biologics Inc (ADMA) .

Click here to see the complete history of Young Kwon’s form 4 insider trades.

Insider Ownership Summary of Young Kwon

Ticker Comapny Transaction Date Type of Owner
MNTA Momenta Pharmaceuticals Inc 2020-10-01 Chief Financial & Bus. Officer
ADMA ADMA Biologics Inc 2024-08-23 director

Young Kwon Latest Holdings Summary

Young Kwon currently owns a total of 2 stocks. Among these stocks, Young Kwon owns 160,633 shares of Momenta Pharmaceuticals Inc (MNTA) as of August 10, 2020, with a value of $8 Million and a weighting of 63.67%. Young Kwon also owns 241,441 shares of ADMA Biologics Inc (ADMA) as of August 23, 2024, with a value of $5 Million and a weighting of 36.33%.

Latest Holdings of Young Kwon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MNTA Momenta Pharmaceuticals Inc 2020-08-10 160,633 52.48 8,430,020
ADMA ADMA Biologics Inc 2024-08-23 241,441 19.92 4,809,915

Holding Weightings of Young Kwon


Young Kwon Form 4 Trading Tracker

According to the SEC Form 4 filings, Young Kwon has made a total of 12 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 652 shares on August 10, 2020, which brought Young Kwon around $21,099.

According to the SEC Form 4 filings, Young Kwon has made a total of 3 transactions in ADMA Biologics Inc (ADMA) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in ADMA Biologics Inc is the sale of 60,000 shares on August 23, 2024, which brought Young Kwon around $1 Million.

Insider Trading History of Young Kwon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Young Kwon Trading Performance

GuruFocus tracks the stock performance after each of Young Kwon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Young Kwon is 10.92%. GuruFocus also compares Young Kwon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Young Kwon within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Young Kwon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Young Kwon

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.49 LIMIT LIMIT LIMIT LIMIT LIMIT

Young Kwon Ownership Network

Ownership Network List of Young Kwon

No Data

Ownership Network Relation of Young Kwon

Insider Network Chart

Young Kwon Owned Company Details

What does Momenta Pharmaceuticals Inc do?

Who are the key executives at Momenta Pharmaceuticals Inc?

Young Kwon is the Chief Financial & Bus. Officer of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief Accounting Officer (PAO) Agnieszka Cieplinska , Chief Scientific Officer Anthony M. Manning , and Chief Legal Officer Alejandra Carvajal .

Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Momenta Pharmaceuticals Inc Insider Transactions

No Available Data

Young Kwon Mailing Address

Above is the net worth, insider trading, and ownership report for Young Kwon. You might contact Young Kwon via mailing address: C/o Momenta Pharmaceuticals Inc., 675 West Kendall Street, Cambridge Ma 02142.